NO20052251L - Nasalt anvendbart farmasoytisk preparat og fremstilling derav. - Google Patents
Nasalt anvendbart farmasoytisk preparat og fremstilling derav.Info
- Publication number
- NO20052251L NO20052251L NO20052251A NO20052251A NO20052251L NO 20052251 L NO20052251 L NO 20052251L NO 20052251 A NO20052251 A NO 20052251A NO 20052251 A NO20052251 A NO 20052251A NO 20052251 L NO20052251 L NO 20052251L
- Authority
- NO
- Norway
- Prior art keywords
- composition
- buffer
- pharmaceutical composition
- osmotic
- preparation
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 239000000825 pharmaceutical preparation Substances 0.000 title abstract 2
- 239000000872 buffer Substances 0.000 abstract 4
- 239000000203 mixture Substances 0.000 abstract 3
- 239000003755 preservative agent Substances 0.000 abstract 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 abstract 2
- 235000011090 malic acid Nutrition 0.000 abstract 2
- 230000003204 osmotic effect Effects 0.000 abstract 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 abstract 2
- 230000002335 preservative effect Effects 0.000 abstract 2
- 239000000080 wetting agent Substances 0.000 abstract 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 abstract 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 abstract 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 abstract 1
- 229910019142 PO4 Inorganic materials 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 239000013543 active substance Substances 0.000 abstract 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 abstract 1
- 239000007864 aqueous solution Substances 0.000 abstract 1
- 229960000686 benzalkonium chloride Drugs 0.000 abstract 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 abstract 1
- 239000000839 emulsion Substances 0.000 abstract 1
- 239000001630 malic acid Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000010452 phosphate Substances 0.000 abstract 1
- 239000000377 silicon dioxide Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Otolaryngology (AREA)
- Epidemiology (AREA)
- Neurology (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Pulmonology (AREA)
- Neurosurgery (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AT0154002A AT413078B (de) | 2002-10-10 | 2002-10-10 | Verwendung eines puffers auf basis von apfelsäure für die herstellung einer nasal applizierbaren zubereitung |
| PCT/AT2003/000306 WO2004032896A1 (de) | 2002-10-10 | 2003-10-09 | Nasal applizierbare pharmazeutische zubereitung und deren herstellung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20052251L true NO20052251L (no) | 2005-05-09 |
Family
ID=32074994
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20052251A NO20052251L (no) | 2002-10-10 | 2005-05-09 | Nasalt anvendbart farmasoytisk preparat og fremstilling derav. |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20060127317A1 (enExample) |
| EP (1) | EP1549288A1 (enExample) |
| JP (1) | JP2006503868A (enExample) |
| AT (1) | AT413078B (enExample) |
| AU (1) | AU2003266811A1 (enExample) |
| CA (1) | CA2501760A1 (enExample) |
| NO (1) | NO20052251L (enExample) |
| PL (1) | PL375762A1 (enExample) |
| WO (1) | WO2004032896A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102007006122A1 (de) * | 2007-02-02 | 2008-08-07 | Krewel Meuselbach Gmbh | Cistusextrakte |
| US20130213393A1 (en) | 2009-12-22 | 2013-08-22 | Evoke Pharma, Inc. | Nasal formulations of metoclopramide |
| WO2015054429A1 (en) * | 2013-10-08 | 2015-04-16 | Innopharma, Inc | Aprepitant oral liquid formulations |
| US11517545B2 (en) | 2016-12-15 | 2022-12-06 | Evoke Pharma, Inc. | Treatment of moderate and severe gastroparesis |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5514670A (en) * | 1993-08-13 | 1996-05-07 | Pharmos Corporation | Submicron emulsions for delivery of peptides |
| AT409081B (de) * | 2000-02-16 | 2002-05-27 | Gebro Pharma Gmbh | Stabile, nasal, oral oder sublingual anwendbare pharmazeutische zubereitung |
-
2002
- 2002-10-10 AT AT0154002A patent/AT413078B/de active
-
2003
- 2003-10-09 US US10/530,969 patent/US20060127317A1/en not_active Abandoned
- 2003-10-09 EP EP03747695A patent/EP1549288A1/de not_active Withdrawn
- 2003-10-09 WO PCT/AT2003/000306 patent/WO2004032896A1/de not_active Ceased
- 2003-10-09 PL PL03375762A patent/PL375762A1/xx not_active Application Discontinuation
- 2003-10-09 AU AU2003266811A patent/AU2003266811A1/en not_active Abandoned
- 2003-10-09 JP JP2004542079A patent/JP2006503868A/ja not_active Withdrawn
- 2003-10-09 CA CA002501760A patent/CA2501760A1/en not_active Abandoned
-
2005
- 2005-05-09 NO NO20052251A patent/NO20052251L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO2004032896A1 (de) | 2004-04-22 |
| PL375762A1 (en) | 2005-12-12 |
| US20060127317A1 (en) | 2006-06-15 |
| AT413078B (de) | 2005-11-15 |
| ATA15402002A (de) | 2005-04-15 |
| AU2003266811A1 (en) | 2004-05-04 |
| JP2006503868A (ja) | 2006-02-02 |
| EP1549288A1 (de) | 2005-07-06 |
| CA2501760A1 (en) | 2004-04-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2342856A1 (en) | Stabilized two-part disinfecting system and compositions and methods related thereto | |
| BRPI0311877B8 (pt) | formulação farmacêutica ácida de insulina com estabilidade aperfeiçoada | |
| ES2150940T3 (es) | Formulacion proteinica que comprende hormona del crecimiento. | |
| ATE535943T1 (de) | Dotierpasten zur erzeugung von p, p+ und n, n+ bereichen in halbleitern | |
| WO2004032979A3 (en) | Acidified chlorite compositions containing nitrogenous stabilizers and systems and methods related thereto | |
| NO20012661L (no) | Fremgangsmåte for å redusere astringens av tinn(II) i dentifriciumsammensetninger | |
| CA2397496A1 (en) | Acidic antimicrobial compositions for treating food and food contact surfaces and methods of use thereof | |
| DE60318867D1 (de) | Lösung zur nagel-verwendung | |
| BR0112461A (pt) | Composições que contém componentes terapeuticamente ativos tendo uma solubilidade aumentada | |
| IS8870A (is) | Lyfjablanda sem felur í sér andrógen | |
| CA2027483A1 (fr) | Procede de preparation d'une solution aqueuse effervescente ayant une action emolliente sur la cuticule des ongles, composition pour la mise en oeuvre dudit procede et traitement cosmetique correspondant | |
| EP1153901A3 (en) | Composition for increasing the vegetable nutritional quality and the use thereof | |
| CA2433558A1 (en) | Dual component dentifrice for reducing mouth odors | |
| CA2256410A1 (en) | Stable pharmaceutical composition of bdnf | |
| DE69630291D1 (de) | Proteinformulierung, die koajulationsfehler viii oder ix in einer saccharose wässriger lösung enthält | |
| PL357132A1 (en) | Stable, nasally, orally or sublingually applicable pharmaceutical preparation | |
| CA2388056A1 (en) | Method of stabilizing dye solutions and stabilized dye compositions | |
| WO2006039231A3 (en) | Topical formulations for the treatment of depression with s adenosyl methionine | |
| WO2005115416A3 (en) | Method of treating with chlorine dioxide | |
| NO20052251L (no) | Nasalt anvendbart farmasoytisk preparat og fremstilling derav. | |
| KR930000096A (ko) | 제제 | |
| BRPI0411114A (pt) | solução aquosa estável de eritropoetina humana, não contendo albumina de soro | |
| EP1552838A4 (en) | RUBROFUSARIN GLYCOSIDE-CONTAINING COMPOSITION | |
| KR950010880A (ko) | 안정한 복합비타민 내복액제 | |
| WO2004075834A3 (en) | Stabilized pharmaceutical compositions of safingol and methods of using the same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |